エムティジェネックス raised its cumulative ordinary profit forecast for the current fiscal year from the previous forecast of ¥700 million to ¥1 billion, updating its record-profit outlook once again. Cumulative second-quarter ordinary profit rose sharply year on year to ¥730 million.
エムティジェネックス announced its earnings on 11 November, reporting consolidated ordinary profit of ¥730 million for the six months ended September 2025, approximately four times the year-earlier level. The result exceeded the previous forecast of ¥460 million. In response, the company raised its full-year ordinary profit forecast from the previous ¥700 million to ¥1 billion.
Cumulative second-quarter sales increased sharply year on year, while the operating profit margin improved. In the latest three-month period, ordinary profit for July–September surged to ¥460 million, confirming a substantial improvement in profitability.
The new full-year forecast implies profit growth of approximately 40% from the previous forecast, and net income for the current fiscal year is also expected to exceed the previous forecast. The second-half plan is an estimate based on first-half results and the underlying assumptions.